Cargando…
Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005222/ https://www.ncbi.nlm.nih.gov/pubmed/35447515 http://dx.doi.org/10.1016/j.jcv.2022.105158 |
_version_ | 1784686410759929856 |
---|---|
author | Mak, Willem A. Koeleman, Johannes G.M. Ong, David S.Y. |
author_facet | Mak, Willem A. Koeleman, Johannes G.M. Ong, David S.Y. |
author_sort | Mak, Willem A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9005222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90052222022-04-13 Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals Mak, Willem A. Koeleman, Johannes G.M. Ong, David S.Y. J Clin Virol Article Elsevier B.V. 2022-06 2022-04-12 /pmc/articles/PMC9005222/ /pubmed/35447515 http://dx.doi.org/10.1016/j.jcv.2022.105158 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mak, Willem A. Koeleman, Johannes G.M. Ong, David S.Y. Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals |
title | Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals |
title_full | Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals |
title_fullStr | Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals |
title_full_unstemmed | Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals |
title_short | Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals |
title_sort | comparison between an in-house sars-cov-2 elispot and the t-spot® discovery sars-cov-2 for the assessment of t cell responses in prior sars-cov-2-infected individuals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005222/ https://www.ncbi.nlm.nih.gov/pubmed/35447515 http://dx.doi.org/10.1016/j.jcv.2022.105158 |
work_keys_str_mv | AT makwillema comparisonbetweenaninhousesarscov2elispotandthetspotdiscoverysarscov2fortheassessmentoftcellresponsesinpriorsarscov2infectedindividuals AT koelemanjohannesgm comparisonbetweenaninhousesarscov2elispotandthetspotdiscoverysarscov2fortheassessmentoftcellresponsesinpriorsarscov2infectedindividuals AT ongdavidsy comparisonbetweenaninhousesarscov2elispotandthetspotdiscoverysarscov2fortheassessmentoftcellresponsesinpriorsarscov2infectedindividuals |